Physician

Andrew James Brenyo, M.D.

According to 2025 Medicare claims, Andrew Brenyo, M.D. (NPI: 1760667737) practices cardiac electrophysiology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from York, SC. This provider's primary affiliated billing organization is CAROLINA CARDIOLOGY ASSOCIATES LLC (NPI: 1134166507; TIN: 57-0989765) and primary practice location at 29732-1174. Brenyo is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Brenyo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,112 traditional Medicare patients, billed 3,865 HCPCS/CPT codes, and received $478,562 in Medicare payments. The top billing code was 93229 (Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional). Part D data shows 3,122 prescription claims across 830 beneficiaries totaling $688,764 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 11 claims. Open Payments data shows 73 records totaling $27,534. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $209,559 to $478,562. Similarly, Part D prescription costs have moved sharply higher in recent years, from $88,826 to $688,764. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,624	3,443	$209,559
2016	1,480	3,276	$238,582
2017	1,909	4,081	$272,391
2018	3,188	6,278	$290,460
2019	2,088	4,773	$311,257
2020	1,819	4,181	$306,342
2021	1,156	4,094	$328,078
2022	1,185	4,309	$531,145
2023	1,261	4,514	$500,485
2024	1,112	3,865	$478,562

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	196	869	$88,826
2016	205	959	$133,837
2017	221	1,059	$180,144
2018	248	1,262	$227,836
2019	319	1,481	$317,145
2020	573	1,760	$384,700
2021	499	1,979	$405,006
2022	541	2,262	$643,804
2023	975	3,997	$890,449
2024	830	3,122	$688,764

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$84
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93229	Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional	225	234	$577
93241	Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days	250	263	$178
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	368	566	$86
93228	Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional	226	235	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	230	306	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	432	22,665	$429,314
Xarelto	Rivaroxaban	79	4,225	$79,778
Entresto	Sacubitril/Valsartan	38	2,280	$49,353
Farxiga	Dapagliflozin Propanediol	20	1,455	$26,995
Multaq	Dronedarone Hcl	12	930	$23,657

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	71	$25,934	BIOTRONIK INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$1,600	CORDIS US CORP.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew James Brenyo, M.D.?

Tedicare shows public-source Medicare data for Andrew James Brenyo, M.D. (NPI 1760667737), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew James Brenyo, M.D. have ACO affiliation data?

Andrew James Brenyo, M.D. is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Andrew James Brenyo, M.D.?

Andrew James Brenyo, M.D. is linked to CAROLINA CARDIOLOGY ASSOCIATES LLC (billing NPI 1134166507) in the available physician profile data.

Does Andrew James Brenyo, M.D. have Open Payments data?

Andrew James Brenyo, M.D. has 73 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.